US Food and Drug Administration advisors voted overwhelmingly in favor of recommending inclusion of a SARS-CoV-2 Omicron component for COVID-19 booster vaccines, with most of those in favor of the vaccine update recommending a bivalent product that includes both the prototype vaccine strain and the Omicron sub-lineage BA.4/BA.5 strain.
The Vaccines and Related Biological Products Advisory Committee's 19-2 vote in favor of Omicron boosters on 28 June, combined with...





